JP2012144532A5 - - Google Patents

Download PDF

Info

Publication number
JP2012144532A5
JP2012144532A5 JP2011280973A JP2011280973A JP2012144532A5 JP 2012144532 A5 JP2012144532 A5 JP 2012144532A5 JP 2011280973 A JP2011280973 A JP 2011280973A JP 2011280973 A JP2011280973 A JP 2011280973A JP 2012144532 A5 JP2012144532 A5 JP 2012144532A5
Authority
JP
Japan
Prior art keywords
formula
phenyl
iii
represented
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011280973A
Other languages
English (en)
Japanese (ja)
Other versions
JP6021166B2 (ja
JP2012144532A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011280973A priority Critical patent/JP6021166B2/ja
Priority claimed from JP2011280973A external-priority patent/JP6021166B2/ja
Publication of JP2012144532A publication Critical patent/JP2012144532A/ja
Publication of JP2012144532A5 publication Critical patent/JP2012144532A5/ja
Application granted granted Critical
Publication of JP6021166B2 publication Critical patent/JP6021166B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011280973A 2010-12-24 2011-12-22 血圧降下剤 Expired - Fee Related JP6021166B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011280973A JP6021166B2 (ja) 2010-12-24 2011-12-22 血圧降下剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010288096 2010-12-24
JP2010288096 2010-12-24
JP2011280973A JP6021166B2 (ja) 2010-12-24 2011-12-22 血圧降下剤

Publications (3)

Publication Number Publication Date
JP2012144532A JP2012144532A (ja) 2012-08-02
JP2012144532A5 true JP2012144532A5 (enExample) 2014-11-27
JP6021166B2 JP6021166B2 (ja) 2016-11-09

Family

ID=46788480

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011280973A Expired - Fee Related JP6021166B2 (ja) 2010-12-24 2011-12-22 血圧降下剤

Country Status (1)

Country Link
JP (1) JP6021166B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5781199B2 (ja) * 2014-06-23 2015-09-16 三井農林株式会社 カテキン代謝物含有組成物
JP6496643B2 (ja) * 2015-09-25 2019-04-03 静岡県公立大学法人 脳神経細胞増殖促進剤
JP6700029B2 (ja) * 2015-12-04 2020-05-27 国立大学法人神戸大学 糖取り込み促進剤
JP7646211B2 (ja) 2019-09-30 2025-03-17 丸善製薬株式会社 アンジオテンシン変換酵素阻害剤、血圧降下剤及び飲食品
JP7290905B2 (ja) * 2020-03-31 2023-06-14 三井農林株式会社 カテキン代謝物の製造方法
JP7490204B2 (ja) 2021-12-22 2024-05-27 国立大学法人大阪大学 脳機能改善剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT68764A (en) * 1991-11-27 1995-07-28 Bioresearch Inc Eatable taste modifiers
JPH1192410A (ja) * 1997-09-25 1999-04-06 Naohiko Sato 抗酸化活性物質
JP2005160402A (ja) * 2003-12-03 2005-06-23 Kiyomitsu Kawasaki 甲殻類フレーバーの製造方法
JP5781199B2 (ja) * 2014-06-23 2015-09-16 三井農林株式会社 カテキン代謝物含有組成物

Similar Documents

Publication Publication Date Title
JP2012144532A5 (enExample)
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
HK1197020A1 (en) Combination of a phosphoinositide 3-kinase inhibitor and a modulator of the janus kinase 2-signal transducer and activator of transcription 5 pathway
PH12012501846A1 (en) Sweet flavor modifier
WO2012147107A3 (en) Novel & improved processes for preparing indoline derivatives and its pharmaceutical composition
MY179876A (en) Sweet flavor modifier
WO2010000372A3 (en) New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
IN2012DN01233A (enExample)
WO2015114395A9 (en) Process for the preparation of vortioxetine salts
MY151295A (en) Pyrimidyl indoline compound
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
WO2008035359A3 (en) Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives
WO2009125434A3 (en) Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
WO2009094560A3 (en) Thienopyranones as kinase inhibitors
WO2010087565A3 (ko) 피페린의 신규한 용도
TNSN07435A1 (en) Novel piperidine carboxylic acid amide derivatives
WO2013014204A3 (en) 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
EP4477222A3 (en) Crystalline 4-(5-chloro-2-isopropylaminopyridin-4-yl)-1h-pyrrole-2-carboxylic acid [1-(3-chlorophenyl)-2-hydroxyethyl]amide hydrochloride salt
MX347157B (es) Derivados de acido 3-heteroaroilamino-propionico sustituidos y su uso como sustancias farmaceuticas.
WO2012128582A3 (en) A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
GEP20125433B (en) α CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT
WO2007032028A8 (en) Thiazolinones and oxazolinones and their use as ptp1b inhibitors
MX2011012201A (es) Combinacion de un inhibidor de cinasa de fosfoinositida-3 y un compuesto anti-diabetico.
EA201201496A1 (ru) Способ ингибирования интегразы вич, способ улучшения фармакокинетики 6-(3-хлор-2-фторбензил)-1-[(2s)-1-гидрокси-3-метилбутан-2-ил]-7-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновой кислоты (варианты), набор, фармацевтическая композиция (варианты) и антиретровирусный агент (варианты)